Medicinal Use of Testosterone and Related Steroids Revisited

被引:21
作者
Tauchen, Jan [1 ]
Jurasek, Michal [2 ]
Huml, Lukas [2 ]
Rimpelova, Silvie [3 ]
机构
[1] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Food Sci, Kamycka 129, Prague 16500, Czech Republic
[2] Univ Chem & Technol Prague, Dept Chem Nat Cpds, Tech 5, Prague 16628 6, Czech Republic
[3] Univ Chem & Technol Prague, Dept Biochem & Microbiol, Tech 5, Prague 16628 6, Czech Republic
来源
MOLECULES | 2021年 / 26卷 / 04期
关键词
androgen receptor; antiandrogens; aging; longevity; medicinal natural products; performance-enhancing drugs; selective androgen receptor modulators; testosterone; ANDROGEN RECEPTOR MODULATOR; NANDROLONE DECANOATE; DOUBLE-BLIND; POSTMENOPAUSAL WOMEN; PHYSICAL FUNCTION; HORMONAL-THERAPY; POTENT; PHARMACOKINETICS; OXANDROLONE; DISCOVERY;
D O I
10.3390/molecules26041032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Testosterone derivatives and related compounds (such as anabolic-androgenic steroids-AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, they have important pharmacological activities that cannot be easily replaced by other drugs and have therapeutic potential in a range of conditions (e.g., wasting syndromes, severe burns, muscle and bone injuries, anemia, hereditary angioedema). Testosterone and related steroids have been in some countries treated as controlled substances, which may affect the availability of these agents for patients who need them for therapeutic reasons in a given country. Although these agents are currently regarded as rather older generation drugs and their use may lead to serious side-effects, they still have medicinal value as androgenic, anabolic, and even anti-androgenic agents. This review summarizes and revisits the medicinal use of compounds based on the structure and biological activity of testosterone, with examples of specific compounds. Additionally, some of the newer androgenic-anabolic compounds are discussed such as selective androgen receptor modulators, the efficacy/adverse-effect profiles of which have not been sufficiently established and which may pose a greater risk than conventional androgenic-anabolic agents.
引用
收藏
页数:20
相关论文
共 114 条
  • [1] Plants in the management of male infertility
    Abarikwu, Sunny O.
    Onuah, Chigozie Linda
    Singh, Shio Kumar
    [J]. ANDROLOGIA, 2020, 52 (03)
  • [2] Development of Dimethandrolone 17β-Undecanoate (DMAU) as an Oral Male Hormonal Contraceptive: Induction of Infertility and Recovery of Fertility in Adult Male Rabbits
    Attardi, Barbara J.
    Engbring, Jean A.
    Gropp, David
    Hild, Sheri Ann
    [J]. JOURNAL OF ANDROLOGY, 2011, 32 (05): : 530 - 540
  • [3] Banks WA, 2009, J DRUG TARGET, V17, P91, DOI [10.1080/10611860802382777, 10.1080/10611860802382777 ]
  • [4] Anabolic Androgenic Steroids
    Barceloux, Donald G.
    Palmer, Robert B.
    [J]. DM DISEASE-A-MONTH, 2013, 59 (06): : 226 - 248
  • [5] Anabolic-androgenic steroid therapy in the treatment of chronic diseases
    Basaria, S
    Wahlstrom, JT
    Dobs, AS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) : 5108 - 5117
  • [6] The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men
    Basaria, Shehzad
    Collins, Lauren
    Dillon, E. Lichar
    Orwoll, Katie
    Storer, Thomas W.
    Miciek, Renee
    Ulloor, Jagadish
    Zhang, Anqi
    Eder, Richard
    Zientek, Heather
    Gordon, Gilad
    Kazmi, Syed
    Sheffied-Moore, Melinda
    Bhasin, Shalender
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2013, 68 (01): : 87 - 95
  • [7] BENNETT MB, 1975, S AFR MED J, V49, P2036
  • [8] Single dose sublingual testosterone and oral sildenafil vs. a dual route/dual release fixed dose combination tablet: a pharmacokinetic comparison
    Bloemers, Jos
    van Rooij, Kim
    de Leede, Leo
    Frijlink, Henderik W.
    Koppeschaar, Hans P. F.
    Olivier, Berend
    Tuiten, Adriaan
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (06) : 1091 - 1102
  • [9] Current Management Options for Hereditary Angioedema
    Bork, Konrad
    [J]. CURRENT ALLERGY AND ASTHMA REPORTS, 2012, 12 (04) : 273 - 280
  • [10] Bromham D. R., 1995, Journal of Obstetrics and Gynaecology (Abingdon), V15, P188, DOI 10.3109/01443619509015498